10x Genomics, Inc.
TXG
$61.65
$1.672.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -4.28% | 2.26% | 5.25% | 1.92% | 2.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -4.28% | 2.26% | 5.25% | 1.92% | 2.02% |
| Cost of Revenue | -6.00% | -1.81% | 1.45% | -4.81% | -11.84% |
| Gross Profit | -3.52% | 4.15% | 7.04% | 5.29% | 9.57% |
| SG&A Expenses | -13.55% | -16.91% | -8.86% | -2.01% | -0.13% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.30% | -11.37% | -6.61% | -3.10% | -3.20% |
| Operating Income | 41.61% | 58.56% | 44.46% | 20.99% | 20.71% |
| Income Before Tax | 5.59% | 87.45% | 77.54% | 58.45% | 65.99% |
| Income Tax Expenses | -95.54% | -6.19% | -26.18% | -51.36% | -19.60% |
| Earnings from Continuing Operations | 11.20% | 85.57% | 76.16% | 58.19% | 64.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.20% | 85.57% | 76.16% | 58.19% | 64.72% |
| EBIT | 41.61% | 58.56% | 44.46% | 20.99% | 20.71% |
| EBITDA | 59.23% | 74.85% | 54.92% | 25.13% | 23.36% |
| EPS Basic | 15.81% | 86.67% | 77.07% | 59.18% | 65.33% |
| Normalized Basic EPS | 45.05% | 67.06% | 52.65% | 23.22% | 24.89% |
| EPS Diluted | 15.51% | 86.71% | 77.13% | 59.30% | 65.41% |
| Normalized Diluted EPS | 45.04% | 67.07% | 52.67% | 23.24% | 24.90% |
| Average Basic Shares Outstanding | 4.54% | 4.05% | 3.56% | 3.07% | 2.72% |
| Average Diluted Shares Outstanding | 4.37% | 4.20% | 3.72% | 3.23% | 2.88% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |